Craif

Craif is an artificial intelligence company in Nagoya, Japan, founded in 2018. It has raised $55.0M across 5 rounds, most recently a $33.0M Series D in August 2026.

Craif (クライフ) | 人々が天寿を全うする社会の実現

Headquarters
Nagoya
Employees
11–50
Founded
2018
Business Model
B2B
Website
craif.com
Total Funding
$55.0M
Last Round
$33.0M Series DAug 2026
Rounds
5

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 5 funding rounds and 6 investors for this company. The full record is or through the API.

About

Craif is a Japanese biotech company spun out of Nagoya University in 2018, pioneering non-invasive early cancer detection through urinary microRNA analysis. The company's proprietary biomarker platform, NANO IP (NANO Intelligence Platform), combines advanced microfluidics, multi-microRNA profiling, and AI algorithms to detect cancer-specific signals in urine samples. Its flagship product, miSignal Scan, enables urine-based cancer risk screening developed through collaborative research with approximately 50 major Japanese university hospitals and cancer research centers. Craif expanded to the United States in 2025, establishing a bioAI lab in San Diego and being accepted into Johnson & Johnson's JLABS incubator. The company is advancing medical device development for pancreatic cancer early detection in both Japan and the US.

Summary

It lists 11–50 employees. It has raised $55.0M in total across 5 rounds, most recently a $33.0M Series D round in Aug 2026. Investors include X&KSK, Daiwa Corporate Investment and ANRI.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series DSeries DAug 2026
$33.0M

Sign up to see all 5 events

Funding: Seed through Series D. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Devoted Health

Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Waltham, United States1001–5000Artificial Intelligence, Healthcare
Series G+Total funding$3.5BOct 2026
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Verily Life Sciences

Verily builds AI-native precision health platforms that help healthcare organizations harmonize d...

Dallas, United States1001–5000Artificial Intelligence, Healthcare
Corporate RoundTotal funding$3.0BMar 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Craif on Indexed.vc
<a href="https://indexed.vc/companies/craif"><img src="https://indexed.vc/api/badge/company/craif" alt="Craif on Indexed.vc" width="260" height="76" /></a>